Ajanta Pharma shareholding pattern

AJANTPHARM

3188.8

59.40 (-1.83%)
Last updated on 20 May, 2026 | 15:59 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Ajanta Pharma Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

66.25%

Mutual Fund

15.22%

Insurance

2.7%

Foreign Institutional Investors

8.26%

Domestic Institutional Investors

0.46%

Retail

7.12%

Others

-0.01%

Total Promoters
MAR '26
66.25%

Summary

Ajanta Pharma share holding pattern reports the following shareholding: Ajanta Pharma Total Promoters is at 66.25%, Mutual Fund at 15.22%, Insurance at 2.70%, Foreign Institutional Investors at 8.26%, Domestic Institutional Investors at 0.46%, and Retail at 7.12%. This breakdown provides a quick snapshot of ownership distribution for Ajanta Pharma share holding pattern in 2026-27.

Ajanta Pharma FAQs

As of 05-2026, the promoter shareholding in Ajanta Pharma stands at 66.25% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Ajanta Pharma is 8.26% and 0.46% respectively.

The retail shareholding of the Ajanta Pharma is 7.12%.

Changes in shareholding patterns of Ajanta Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Ajanta Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost